Efficacy of the digital health application ORIKO(R) for attention-deficit/hyperactivity disorder (ADHD) in adults: Protocol of a randomized controlled trial
Attention-deficit/hyperactivity disorder (ADHD) often continues into adulthood and affects several million adults in Germany. Many do not receive timely, evidence-based treatment because of long waiting times and limited access to…
Suggested reading